Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy

F. Leyva, P. W. X. Foley, B. Stegemann, Joanna Ward, L. L. Ng, Michael Frenneaux, F. Regoli, Rhea Smith, A. Auricchio

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: To develop and validate a prognostic risk index of cardiovascular mortality after cardiac resynchronisation therapy (CRT).

Design: Prospective cohort study.

Setting: District general hospital.

Patients: 148 patients with heart failure (mean age 66.7 (SD 10.4) years), New York Heart Association class III or IV, LVEF <35%) who underwent CRT.

Interventions: CRT device implantation.

Main outcome measures: Value of a composite index in predicting cardiovascular mortality, validated internally by bootstrapping. The predictive value of the index was compared to factors that are known to predict mortality in patients with heart failure.

Results: All patients underwent assessment of 16 prognostic risk factors, including cardiovascular magnetic resonance (CMR) measures of myocardial scarring (gadolinium-hyperenhancement) and dyssynchrony, before implantation. Clinical events were assessed after a median follow-up of 913 (interquartile range 967) days. At follow-up, 37/148 (25%) of patients died from cardiovascular causes. In Cox proportional hazards analyses, (DSC) Dyssynchrony, posterolateral Scar location (both p<0.0001) and Creatinine (p = 0.0046) emerged as independent predictors of cardiovascular mortality. The DSC index, derived from these variables combined, emerged as a powerful predictor of cardiovascular mortality. Compared to patients with a DSC <3, cardiovascular mortality in patients in the intermediate DSC index (3-5; HR: 11.1 (95% confidence interval (CI) 3.00 to 41.1), p = 0.0003) and high DSC index (>= 5; HR: 30.5 (95% CI 9.15 to 101.8), p<0.0001) were higher. Bootstrap validation confirmed excellent calibration and internal validity of the prediction model.

Conclusion: The DSC index, derived from a standard CMR scan and plasma creatinine before implantation, is a powerful predictor of cardiovascular mortality after CRT.

Original languageEnglish
Pages (from-to)1619-1625
Number of pages7
JournalHeart
Volume95
Issue number19
Early online date9 Jul 2009
DOIs
Publication statusPublished - Oct 2009

Keywords

  • chronic heart-failure
  • cardiovascular magnetic-resonance
  • idiopathic dilated cardiomyopathy
  • left-ventricular dyssynchrony
  • resynchronization therapy
  • intraventricular dyssynchrony
  • neurohormonal activation
  • phase-analysis
  • renal-function
  • asychrony

Cite this

Leyva, F., Foley, P. W. X., Stegemann, B., Ward, J., Ng, L. L., Frenneaux, M., ... Auricchio, A. (2009). Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Heart, 95(19), 1619-1625. https://doi.org/10.1136/hrt.2009.173880

Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. / Leyva, F.; Foley, P. W. X.; Stegemann, B.; Ward, Joanna; Ng, L. L.; Frenneaux, Michael; Regoli, F.; Smith, Rhea; Auricchio, A.

In: Heart, Vol. 95, No. 19, 10.2009, p. 1619-1625.

Research output: Contribution to journalArticle

Leyva, F, Foley, PWX, Stegemann, B, Ward, J, Ng, LL, Frenneaux, M, Regoli, F, Smith, R & Auricchio, A 2009, 'Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy', Heart, vol. 95, no. 19, pp. 1619-1625. https://doi.org/10.1136/hrt.2009.173880
Leyva, F. ; Foley, P. W. X. ; Stegemann, B. ; Ward, Joanna ; Ng, L. L. ; Frenneaux, Michael ; Regoli, F. ; Smith, Rhea ; Auricchio, A. / Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. In: Heart. 2009 ; Vol. 95, No. 19. pp. 1619-1625.
@article{0b9cd92a7ff4496e87bb628894dc8350,
title = "Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy",
abstract = "Objective: To develop and validate a prognostic risk index of cardiovascular mortality after cardiac resynchronisation therapy (CRT).Design: Prospective cohort study.Setting: District general hospital.Patients: 148 patients with heart failure (mean age 66.7 (SD 10.4) years), New York Heart Association class III or IV, LVEF <35{\%}) who underwent CRT.Interventions: CRT device implantation.Main outcome measures: Value of a composite index in predicting cardiovascular mortality, validated internally by bootstrapping. The predictive value of the index was compared to factors that are known to predict mortality in patients with heart failure.Results: All patients underwent assessment of 16 prognostic risk factors, including cardiovascular magnetic resonance (CMR) measures of myocardial scarring (gadolinium-hyperenhancement) and dyssynchrony, before implantation. Clinical events were assessed after a median follow-up of 913 (interquartile range 967) days. At follow-up, 37/148 (25{\%}) of patients died from cardiovascular causes. In Cox proportional hazards analyses, (DSC) Dyssynchrony, posterolateral Scar location (both p<0.0001) and Creatinine (p = 0.0046) emerged as independent predictors of cardiovascular mortality. The DSC index, derived from these variables combined, emerged as a powerful predictor of cardiovascular mortality. Compared to patients with a DSC <3, cardiovascular mortality in patients in the intermediate DSC index (3-5; HR: 11.1 (95{\%} confidence interval (CI) 3.00 to 41.1), p = 0.0003) and high DSC index (>= 5; HR: 30.5 (95{\%} CI 9.15 to 101.8), p<0.0001) were higher. Bootstrap validation confirmed excellent calibration and internal validity of the prediction model.Conclusion: The DSC index, derived from a standard CMR scan and plasma creatinine before implantation, is a powerful predictor of cardiovascular mortality after CRT.",
keywords = "chronic heart-failure, cardiovascular magnetic-resonance, idiopathic dilated cardiomyopathy, left-ventricular dyssynchrony, resynchronization therapy, intraventricular dyssynchrony, neurohormonal activation, phase-analysis, renal-function, asychrony",
author = "F. Leyva and Foley, {P. W. X.} and B. Stegemann and Joanna Ward and Ng, {L. L.} and Michael Frenneaux and F. Regoli and Rhea Smith and A. Auricchio",
year = "2009",
month = "10",
doi = "10.1136/hrt.2009.173880",
language = "English",
volume = "95",
pages = "1619--1625",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "19",

}

TY - JOUR

T1 - Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy

AU - Leyva, F.

AU - Foley, P. W. X.

AU - Stegemann, B.

AU - Ward, Joanna

AU - Ng, L. L.

AU - Frenneaux, Michael

AU - Regoli, F.

AU - Smith, Rhea

AU - Auricchio, A.

PY - 2009/10

Y1 - 2009/10

N2 - Objective: To develop and validate a prognostic risk index of cardiovascular mortality after cardiac resynchronisation therapy (CRT).Design: Prospective cohort study.Setting: District general hospital.Patients: 148 patients with heart failure (mean age 66.7 (SD 10.4) years), New York Heart Association class III or IV, LVEF <35%) who underwent CRT.Interventions: CRT device implantation.Main outcome measures: Value of a composite index in predicting cardiovascular mortality, validated internally by bootstrapping. The predictive value of the index was compared to factors that are known to predict mortality in patients with heart failure.Results: All patients underwent assessment of 16 prognostic risk factors, including cardiovascular magnetic resonance (CMR) measures of myocardial scarring (gadolinium-hyperenhancement) and dyssynchrony, before implantation. Clinical events were assessed after a median follow-up of 913 (interquartile range 967) days. At follow-up, 37/148 (25%) of patients died from cardiovascular causes. In Cox proportional hazards analyses, (DSC) Dyssynchrony, posterolateral Scar location (both p<0.0001) and Creatinine (p = 0.0046) emerged as independent predictors of cardiovascular mortality. The DSC index, derived from these variables combined, emerged as a powerful predictor of cardiovascular mortality. Compared to patients with a DSC <3, cardiovascular mortality in patients in the intermediate DSC index (3-5; HR: 11.1 (95% confidence interval (CI) 3.00 to 41.1), p = 0.0003) and high DSC index (>= 5; HR: 30.5 (95% CI 9.15 to 101.8), p<0.0001) were higher. Bootstrap validation confirmed excellent calibration and internal validity of the prediction model.Conclusion: The DSC index, derived from a standard CMR scan and plasma creatinine before implantation, is a powerful predictor of cardiovascular mortality after CRT.

AB - Objective: To develop and validate a prognostic risk index of cardiovascular mortality after cardiac resynchronisation therapy (CRT).Design: Prospective cohort study.Setting: District general hospital.Patients: 148 patients with heart failure (mean age 66.7 (SD 10.4) years), New York Heart Association class III or IV, LVEF <35%) who underwent CRT.Interventions: CRT device implantation.Main outcome measures: Value of a composite index in predicting cardiovascular mortality, validated internally by bootstrapping. The predictive value of the index was compared to factors that are known to predict mortality in patients with heart failure.Results: All patients underwent assessment of 16 prognostic risk factors, including cardiovascular magnetic resonance (CMR) measures of myocardial scarring (gadolinium-hyperenhancement) and dyssynchrony, before implantation. Clinical events were assessed after a median follow-up of 913 (interquartile range 967) days. At follow-up, 37/148 (25%) of patients died from cardiovascular causes. In Cox proportional hazards analyses, (DSC) Dyssynchrony, posterolateral Scar location (both p<0.0001) and Creatinine (p = 0.0046) emerged as independent predictors of cardiovascular mortality. The DSC index, derived from these variables combined, emerged as a powerful predictor of cardiovascular mortality. Compared to patients with a DSC <3, cardiovascular mortality in patients in the intermediate DSC index (3-5; HR: 11.1 (95% confidence interval (CI) 3.00 to 41.1), p = 0.0003) and high DSC index (>= 5; HR: 30.5 (95% CI 9.15 to 101.8), p<0.0001) were higher. Bootstrap validation confirmed excellent calibration and internal validity of the prediction model.Conclusion: The DSC index, derived from a standard CMR scan and plasma creatinine before implantation, is a powerful predictor of cardiovascular mortality after CRT.

KW - chronic heart-failure

KW - cardiovascular magnetic-resonance

KW - idiopathic dilated cardiomyopathy

KW - left-ventricular dyssynchrony

KW - resynchronization therapy

KW - intraventricular dyssynchrony

KW - neurohormonal activation

KW - phase-analysis

KW - renal-function

KW - asychrony

U2 - 10.1136/hrt.2009.173880

DO - 10.1136/hrt.2009.173880

M3 - Article

VL - 95

SP - 1619

EP - 1625

JO - Heart

JF - Heart

SN - 1355-6037

IS - 19

ER -